| scholarly article | Q13442814 |
| P50 | author | James B. Rowe | Q24265625 |
| Kamen A Tsvetanov | Q60053741 | ||
| Luca Passamonti | Q47712272 | ||
| P2093 | author name string | L Su | |
| E Mak | |||
| J T O'Brien | |||
| R Arnold | |||
| P S Jones | |||
| R J Borchert | |||
| W R Bevan-Jones | |||
| P2860 | cites work | TREM2 Variants in Alzheimer's Disease | Q22250873 |
| Variant of TREM2 Associated with the Risk of Alzheimer's Disease | Q22250874 | ||
| An 18-kDa translocator protein (TSPO) polymorphism explains differences in binding affinity of the PET radioligand PBR28 | Q24599479 | ||
| Microglial Priming and Alzheimer's Disease: A Possible Role for (Early) Immune Challenges and Epigenetics? | Q26739495 | ||
| Convergent molecular defects underpin diverse neurodegenerative diseases. | Q49832958 | ||
| [11C]PK11195 binding in Alzheimer disease and progressive supranuclear palsy. | Q53397590 | ||
| Innate immune activation in Alzheimer’s disease. | Q55289589 | ||
| Microglial priming in Alzheimer's disease. | Q55358469 | ||
| Nonsteroidal Antiinflammatory Drugs and the Risk of Alzheimer's Disease | Q57782086 | ||
| Activity and Connectivity Differences Underlying Inhibitory Control Across the Adult Life Span | Q58763317 | ||
| In vivo evidence for pre-symptomatic neuroinflammation in a MAPT mutation carrier | Q64228804 | ||
| Do nonsteroidal antiinflammatory drugs reduce the risk of Alzheimer's disease? | Q77497782 | ||
| Modular preprocessing pipelines can reintroduce artifacts into fMRI data | Q91151432 | ||
| Mild cognitive impairment: clinical characterization and outcome | Q28140626 | ||
| A fast diffeomorphic image registration algorithm | Q28243996 | ||
| Improved optimization for the robust and accurate linear registration and motion correction of brain images | Q29547542 | ||
| The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease | Q29547554 | ||
| An improved framework for confound regression and filtering for control of motion artifact in the preprocessing of resting-state functional connectivity data | Q30445189 | ||
| A method for making group inferences from functional MRI data using independent component analysis | Q30660698 | ||
| Conversion of amyloid positive and negative MCI to AD over 3 years: an 11C-PIB PET study. | Q33697980 | ||
| Cognitive function over time in the Alzheimer's Disease Anti-inflammatory Prevention Trial (ADAPT): results of a randomized, controlled trial of naproxen and celecoxib | Q34077849 | ||
| The Cambridge Centre for Ageing and Neuroscience (Cam-CAN) study protocol: a cross-sectional, lifespan, multidisciplinary examination of healthy cognitive ageing. | Q34447380 | ||
| Cytokine expression and microglial activation in progressive supranuclear palsy. | Q35388683 | ||
| Decoding subject-driven cognitive states with whole-brain connectivity patterns | Q35610139 | ||
| Extrinsic and Intrinsic Brain Network Connectivity Maintains Cognition across the Lifespan Despite Accelerated Decay of Regional Brain Activation | Q36690110 | ||
| Microglia, amyloid, and glucose metabolism in Parkinson's disease with and without dementia | Q36775208 | ||
| The nuisance of nuisance regression: spectral misspecification in a common approach to resting-state fMRI preprocessing reintroduces noise and obscures functional connectivity | Q37138292 | ||
| Integrated strategy for improving functional connectivity mapping using multiecho fMRI | Q37218288 | ||
| Source-based morphometry: the use of independent component analysis to identify gray matter differences with application to schizophrenia | Q37362275 | ||
| Complement and microglia mediate early synapse loss in Alzheimer mouse models. | Q37391481 | ||
| Neuroimaging of Inflammation in Memory and Related Other Disorders (NIMROD) study protocol: a deep phenotyping cohort study of the role of brain inflammation in dementia, depression and other neurological illnesses | Q37576743 | ||
| Immune attack: the role of inflammation in Alzheimer disease. | Q38492631 | ||
| Imaging of neuroinflammation in dementia: a review | Q38589039 | ||
| Microglial genes regulating neuroinflammation in the progression of Alzheimer's disease. | Q38620321 | ||
| Challenges in measuring individual differences in functional connectivity using fMRI: The case of healthy aging | Q38764140 | ||
| Self, cortical midline structures and the resting state: Implications for Alzheimer's disease | Q38846613 | ||
| (11)C-PBR28 binding to translocator protein increases with progression of Alzheimer's disease | Q39137978 | ||
| Detection and DNA quantification of Enterococcus casseliflavus in a foal with septic meningitis | Q40101116 | ||
| In vivo imaging of microglial activation with [11C](R)-PK11195 PET in progressive supranuclear palsy | Q42482808 | ||
| In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease | Q42484469 | ||
| In-vivo measurement of activated microglia in dementia | Q43713539 | ||
| Reference and target region modeling of [11C]-(R)-PK11195 brain studies | Q45303765 | ||
| Microglia, amyloid, and cognition in Alzheimer's disease: An [11C](R)PK11195-PET and [11C]PIB-PET study | Q46373170 | ||
| Comparison of four 11C-labeled PET ligands to quantify translocator protein 18 kDa (TSPO) in human brain: (R)-PK11195, PBR28, DPA-713, and ER176-based on recent publications that measured specific-to-non-displaceable ratios | Q47100792 | ||
| Clinically Different Stages of Alzheimer's Disease Associated by Amyloid Deposition with [11C]-PIB PET Imaging | Q48096265 | ||
| Naproxen and celecoxib do not prevent AD in early results from a randomized controlled trial | Q48187875 | ||
| SPM analysis of parametric (R)-[11C]PK11195 binding images: plasma input versus reference tissue parametric methods | Q48239908 | ||
| Influence of microglial activation on neuronal function in Alzheimer's and Parkinson's disease dementia. | Q48529217 | ||
| Parametric imaging of ligand-receptor binding in PET using a simplified reference region model. | Q48546793 | ||
| Microglia: Phagocytosing to Clear, Sculpt, and Eliminate. | Q48602947 | ||
| P433 | issue | 36 | |
| P921 | main subject | Alzheimer's disease | Q11081 |
| P304 | page(s) | 7218-7226 | |
| P577 | publication date | 2019-07-18 | |
| P1433 | published in | Journal of Neuroscience | Q1709864 |
| P1476 | title | Neuroinflammation and Functional Connectivity in Alzheimer's Disease: Interactive Influences on Cognitive Performance | |
| P478 | volume | 39 |
| Q99555843 | Activate or Inhibit? Implications of Autophagy Modulation as a Therapeutic Strategy for Alzheimer's Disease |
| Q94544420 | Altered Patterns of Functional Connectivity and Causal Connectivity in Salience Subnetwork of Subjective Cognitive Decline and Amnestic Mild Cognitive Impairment |
| Q101237460 | Chia seeds as a potential cognitive booster in the APP23 Alzheimer's disease model |
| Q92132197 | Classification Methods Based on Complexity and Synchronization of Electroencephalography Signals in Alzheimer's Disease |
| Q90722520 | PPARγ and Cognitive Performance |
| Q89790628 | The Dual Role of Microglia in the Progression of Alzheimer's Disease |
| Q94471952 | The combined effects of microglia activation and brain glucose hypometabolism in early-onset Alzheimer's disease |
Search more.